טוען...
Cold agglutinin disease: current challenges and future prospects
Cold agglutinin disease (CAD) is a complement-dependent, classical pathway-mediated immune hemolytic disease, accounting for 15–25% of autoimmune hemolytic anemia, and at the same time, a distinct clonal B-cell lymphoproliferative disorder of the bone marrow. The disease burden is often high, but no...
שמור ב:
| הוצא לאור ב: | J Blood Med |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6497508/ https://ncbi.nlm.nih.gov/pubmed/31114413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S177621 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|